Companion diagnostics are FDA-approved drugs that target a a certain marker or genetic mutation associated with a patient's response. "For a current listing of FDA approved companion diagnostics click here."
ALK 2p23 rearrangement by FISH
BRAF Mutation Analysis by Next Generation Sequencing
Chronic Lymphocytic Leukemia (CLL) Panel by FISH
EGFR Mutation Analysis by Next Generation Sequencing
HER2/neu breast cancer by FISH
HER2/neu gastric cancer by FISH